Cradle Genomics

About:

Cradle Genomics is a creator of a novel prenatal testing methodology

Website: https://www.cradlegenomics.com/

Top Investors: Alexandria Real Estate Equities, Illumina Ventures, Section 32, Pacific West Bank, Listwin Ventures

Description:

At Cradle Genomics, their mission is to provide knowledge that helps every pregnancy. They're dedicated to the transformation of non-invasive prenatal testing (NIPT) by offering the most comprehensive fetal genetic analysis and pregnancy health screening solutions at the earliest stages of pregnancy. Cradle Genomics is newly formed with their headquarters based in San Diego and additional R&D operations located in Detroit. Cradle tests are based on the genetic analysis of fetal cells that are quickly collected during a first trimester visit with no risk to the mother or developing fetus.